Fundraising Fox
/Companies
Sign in

InkVivo

Lugano, CH · 1 known investors

Find your way into InkVivo

Each arrow is one introduction. Sign up to fill in the first one.

208 people can intro you to Stefano

Ask Lorenzo Leoni to introduce you to Stefano Cerutti

You →Lorenzo · together at InkVivo →Stefano

Sign up to find every way you can get introduced to InkVivo

  • Your email: who you already know at InkVivo, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the InkVivo team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

InkVivo Technologies develops polymer-based drug delivery platforms (GARD/gastroretentive and SHEALD/injectable) for controlled, localized, and sustained release of small molecules and biologics. An ETH Zurich spin-off, it works with pharmaceutical and nutraceutical partners to improve bioavailability and patient adherence, with programs targeting iron deficiency anemia and neurodegenerative diseases.

BiotechDeep TechMedical DevicesNew Materials

Founders & leadership

EG
Elia GuzziCo-Founder & CEO
SCStefano Cerutti
Stefano CeruttiCo-Founder & COOStefano Cerutti is co-founder and COO of InkVivo Technologies, an ETH Zurich spin-off developing polymer-based drug delivery platforms. He brings five years of team leadership and project management experience, combined with an engineering background and business strategy education from an Executive MBA program.
LTLeonardo Tognola
Leonardo TognolaCo-Founder & CTO

Investors · 1

Related companies · 2

InVivo BiosystemsBiotechnology company providing solutions for genetic research and drug discovery.
Northwest BiotherapeuticsNW Bio develops personalized dendritic cell-based cancer vaccines intended to treat a range of solid tumor cancers as an alternative to chemotherapy. Its clinical-stage products target cancers including glioblastoma, inoperable solid tumors, ovarian cancer, and prostate cancer.

Companies working in the same space as InkVivo.

Frequently asked questions

What does InkVivo do?
InkVivo Technologies develops polymer-based drug delivery platforms (GARD/gastroretentive and SHEALD/injectable) for controlled, localized, and sustained release of small molecules and biologics. An ETH Zurich spin-off, it works with pharmaceutical and nutraceutical partners to improve bioavailability and patient adherence, with programs targeting iron deficiency anemia and neurodegenerative diseases.
Who founded InkVivo?
InkVivo was founded by Elia Guzzi, Stefano Cerutti, Leonardo Tognola.
Who are InkVivo's investors?
InkVivo's investors include TiVenture SA.
Where is InkVivo headquartered?
InkVivo is headquartered in Lugano, CH.